07 Jan 2001

Cholipin 20 - España

Updated: 07 Jan 2001

Cholipin 20 grageas

Disquinesias biliares, espasmos biliares. Síndrome post-colecistectomía. Dispepsias por alteración de la secreción biliar. Litiasis biliar no obstructiva.

Cholipin 20 Description, Presentation and Dosage

Cholipin 20 Description

Cholipin 20 Drug Class Description

Colagogos y colereticos en asociacion salvo a05c

Cholipin 20 Drug Description

GRAGEAS

Cholipin 20 Presentation

Cholipin 20 Presentation

1-2 grageas 3 veces al día, preferentemente antes de las comidas.

Cholipin 20 Manufacturer

BOEHRINGER INGELHEIM

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this free resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately. Content is arranged into sections with disease awareness information, mode of action videos, first-line treatment options, links to useful external hyperammonaemia content and more… 

Cholipin 20 Dosage

Cholipin 20 Precautions, Reactions and Contraindications

Cholipin 20 Special Precautions

Related Drugs - Gastroenterologia

Back to top